Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MaxATAC: genome-scale transcription-factor binding prediction from ATAC-seq with deep neural networks

ABSTRACT: maxATAC: genome-scale transcription-factor binding prediction from ATAC-seq with deep neural networks

PROVIDER: PRJNA808389 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18072314_1.fastq.gz	Fastqsanger.gz
	SRR18072314_2.fastq.gz	Fastqsanger.gz
	SRR18072315_1.fastq.gz	Fastqsanger.gz
	SRR18072315_2.fastq.gz	Fastqsanger.gz
	SRR18072316_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

maxATAC: genome-scale transcription-factor binding prediction from ATAC-seq with deep neural networks

Project description:Transcription factors read the genome, fundamentally connecting DNA sequence to gene expression across diverse cell types. Determining how, where, and when TFs bind chromatin will advance our understanding of gene regulatory networks and cellular behavior. The 2017 ENCODE-DREAM in vivo Transcription-Factor Binding Site (TFBS) Prediction Challenge highlighted the value of chromatin accessibility data to TFBS prediction, establishing state-of-the-art methods. Yet, while Assay-for-Transposase-Accessible-Chromatin (ATAC)-seq datasets grow exponentially, suboptimal motif scanning is commonly used for TFBS prediction from ATAC-seq. Here, we present “maxATAC”, a suite of user-friendly, deep neural network models for genome-wide TFBS prediction from ATAC-seq in any cell type. With models available for 127 human TFs, maxATAC is the largest collection of state-of-the-art TFBS models to date. maxATAC performance extends to primary cells and single-cell ATAC-seq, enabling state-of-the-art TFBS prediction in vivo. We demonstrate maxATAC’s capabilities by identifying TFBS associated with allele-dependent chromatin accessibility at atopic dermatitis genetic risk loci.

2022-02-21 | GSE197009 | GEO

GNPS - Deep Neural Networks for Classification of LC-MS Spectral Peaks

Project description:Files associated with the manuscript "Deep Neural Networks for Classification of LC-MS Spectral Peaks"

2019-08-08 | MSV000084186 | GNPS

Deep Neural Networks for Classification of LC-MS Spectral Peaks

Project description:Files associated with the manuscript "Deep Neural Networks for Classification of LC-MS Spectral Peaks"

2019-08-08 | MSV000084186 | MassIVE

Artificial neural networks enable genome-scale simulations of intracellular signaling

Project description:Artificial neural networks enable genome-scale simulations of intracellular signaling

| PRJNA836421 | ENA

Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis

Project description:The incorporation of machine learning methods into proteomics workflows improves the identification of disease-relevant biomarkers and biological pathways. However, machine learning models, such as deep neural networks, typically suffer from lack of interpretability. Here, we present a deep learning approach to combine biological pathway analysis and biomarker identification to increase the interpretability of proteomics experiments. Our approach integrates a priori knowledge of the relationships between proteins and biological pathways and biological processes into sparse neural networks to create biologically informed neural networks. We employ these networks to differentiate between clinical subphenotypes of septic acute kidney injury and COVID-19, as well as acute respiratory distress syndrome of different aetiologies. To gain biological insight into the complex syndromes, we utilize feature attribution-methods to introspect the networks for the identification of proteins and pathways important for distinguishing between subtypes. The algorithms are implemented in a freely available open source Python-package (https://github.com/InfectionMedicineProteomics/BINN).

2023-09-05 | PXD044264 | Pride

Prediction of glycopeptide fragment mass spectra by deep learning

Project description:Deep learning has achieved a notable success in mass spectrometry-based proteomics and is now emerging in glycoproteomics. While various deep learning models can predict fragment mass spectra of peptides with good accuracy, they cannot cope with the non-linear glycan structure in an intact glycopeptide. Herein, we propose a deep learning-based approach for the prediction of fragment spectra of intact glycopeptides. Our model adopts tree-structured long-short term memory networks to process the glycan moiety and a graph neural network architecture to incorporate potential fragmentation pathways of a specific glycan structure. This feature is beneficial to model explainability and differentiation ability of glycan structural isomers. We further demonstrated that predicted spectral libraries can be used for analyzing DIA data of glycopeptides as a supplement for library completeness. We expect that this work will provide a valuable deep learning resource for glycoproteomics.

2023-12-17 | PXD045248 |

HAVOC: Small-scale histomic mapping of biodiversity across entire tumor specimens using deep neural networks

Project description:Intra-tumoral heterogeneity can wreak havoc on current precision medicine strategies due to challenges in sufficient sampling of geographically separated areas of biodiversity distributed across centimeter-scale tumor distances. In particular, modern tissue profiling approaches are still largely designed to only interrogate small tumor fragments; which may constitute a minute and non-representative fraction of the overall neoplasm. To address this gap, we developed a pipeline that leverages deep learning to define topographic histomorphologic fingerprints of tissue and create Histomic Atlases of Variation Of Cancers (HAVOC). Importantly, using a number of spatially-resolved readouts, including mass-spectrometry-based proteomics and immunohistochemisy, we demonstrate that these personalized atlases of histomic variation can define regional cancer boundaries with distinct biological programs. Using larger tumor specimens, we show that HAVOC can map spatial organization of cancer biodiversity spanning tissue coordinates separated by multiple centimeters. By applying this tool to guide profiling of 19 distinct geographic partitions from 6 high-grade gliomas, HAVOC revealed that distinct states of differentiation can often co-exist and be regionally distributed across individual tumors. Finally,to highlight generalizability, we further benchmark HAVOC on additional tumor types and experimental models of heterogeneity. Together, we establish HAVOC as a versatile and accessible tool to generate small-scale maps of tissue heterogeneity and guide regional deployment of molecular resources to relevant and biodiverse tumor niches.

2023-08-23 | PXD037548 | Pride

ICEBERG: Neural Spectral Prediction for Structure Elucidation with Tandem Mass Spectrometry

Project description:Contains supplementary data for the paper Neural Spectral Prediction for Structure Elucidation with Tandem Mass Spectrometry.

2025-05-24 | MSV000097986 | MassIVE

ICEBERG: Neural Spectral Prediction for Structure Elucidation with Tandem Mass Spectrometry

Project description:Contains supplementary data for the paper Neural Spectral Prediction for Structure Elucidation with Tandem Mass Spectrometry.

2025-05-14 | MSV000097893 | MassIVE

Deciphering PTM Crosstalk on Hsp90: Integrating Deep Learning for Drug Sensitivity Prediction

Project description:Post-translational modification (PTM) of proteins regulates cellular proteostasis by expanding protein functional diversity. This naturally leads to increased proteome complexity as the result of PTM crosstalk. Here, we used a heavily modified molecular chaperone, Heat shock protein-90 (Hsp90), to investigate this concept. Hsp90 is at the hub of proteostasis and cellular signaling networks in cancer and is, therefore, an attractive therapeutic target in cancer. We showed that deletion of HDAC3 and HDAC8 in human cells led to increased binding of Hsp90 to both ATP and drugs. When bound to its ATP-competitive inhibitor, Hsp90 from both HDAC3 and HDAC8 knock out human cells exhibited similar PTMs, mainly phosphorylation and acetylation, and created a common proteomic network signature. We used both a deep-learning artificial intelligence (AI) prediction model and data based on mass-spectrometry analysis of Hsp90 isolated from the mammalian cells bound to its drugs to decipher PTM crosstalk. The alignment of data from both methods demonstrates that the deep-learning prediction model offers a highly efficient and rapid approach for deciphering PTM crosstalk on complex proteins such as Hsp90.

2025-09-08 | PXD061927 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data